Outreach Messages Up Well-Child Visits, Vaccination Completion

TUESDAY, Nov. 22, 2022 (HealthDay News) -- Outreach messages delivered via electronic health record patient portals increase the rates of scheduling and completing well-child visits and receiving the COVID-19 vaccine, according to a study published online Nov. 18 in JAMA Network Open.
Anne E. Berset, from the Cincinnati Children’s Hospital Medical Center, and colleagues examined the effectiveness of patient portal outreach messages, with and without the date of the last well-child care, on the scheduling and completion of well-child visits and completion of vaccinations within two weeks. The analysis included 945 participants randomly assigned to the standard message, tailored message, or no message (control) groups.
The researchers found that scheduling rates were 18.4 percent in the standard message group (adjusted risk ratio [aRR], 1.97) and 14.9 percent in the tailored message group (aRR, 1.57) versus the control group (9.5 percent). Similarly, well-child care visit completion rates were higher in the standard message group (aRR, 1.92) and tailored message group (aRR, 1.52) versus the control group. Rates of receiving the COVID-19 vaccine among eligible children were 16.7 percent in the standard message group versus 4.8 percent in the tailored message group (aRR, 3.41) and 3.7 percent in the control group (aRR, 4.84).
"Additional efforts are needed to reengage at-risk populations and recover preventive services missed during the pandemic," the authors write.
Related Posts
La mayoría de los clérigos concurren con la ciencia sobre el tratamiento para la depresión, según un estudio
VIERNES, 13 de enero de 2023 (HealthDay News) -- Las preocupaciones de que los...
Male Physicians Receive More and Higher Payments From Medical Companies
WEDNESDAY, Oct. 5, 2022 (HealthDay News) -- Male physicians receive...
Un estudio con ratones apunta a un posible avance contra las lesiones de médula espinal
VIERNES, 12 de noviembre de 2021 (HealthDay News) -- Las lesiones de médula...
Vedolizumab Aids Remission in Chronic Pouchitis After Ileal Pouch-Anal Anastomosis
FRIDAY, March 31, 2023 (HealthDay News) -- For patients with chronic pouchitis...
